Unichem Laboratories Profile
Unichem Laboratories Limited engages in the manufacture, development, and sourcing of generic medicines for the Indian market. It operates in therapeutic areas like gastro-intestinal, cardio-vascular, diabetes, psychiatry, neurology, anti-bacterials, anti-infectives and pain management, among others. The company operates in 25 developing and regulated countries. It is exporting to 29 countries worldwide. The company operates in three divisions: Unisearch, Unichem Pharma, and Neu Foreva.
Unichem manufactures a range of formulations, principally for the Indian and international markets. Its key therapeutic focus comprises the cardiovascular, diabetes, psychiatry, neurology, musculo-skeletal diseases (NSAIDs), gastro-intestinal, anti-infective and women’s health segments, among others. The company’s international business comprised direct exports, as well as operations of Niche Generics, its 60:40 ratio European joint venture. Its major products are Bisoprolol and Citalopram.
Unisearch
Unisearch division focuses on lifestyle-related ailments, including cardiovascular and diabetes. The company’s cardiovascular products include Losar (losartan), Losar H, Losar A, combination drugs (ARBs plus ACE I), Corvadil group (amlodipine), TGTOR (atorvastatin), Clodrel (clopidogrel) and Betanif (nifedipine and atenolol). It launched Losar Beta, an ARB & beta-blocker combination; and acholestrol-reducing product Ezetib (ezetimibe) during the year 2004. The company also extended the product basket through the introduction of Loram (a combination drug of losartan and ramipril). The company’s diabetology provides a complementary solution to cardiovascular ailments. The G-TASE G and Metride are some of the products Unichem introduced in 2003-04.
Unichem Pharma
Unichem Pharma division focuses on common ailments that comprise acute therapy (pain management, gastro-intestinal, antiinfective and anti-allergic, among others). The products of this division belong to the musculo-skeletal (pain management) or NSAIDs, gastro-intestinals and anti-infectives therapeutic areas that address acute and conventional ailments.
The company has two products, Valcox tablets and injections. Apart from Valdecoxib, Unichem has three other COX 2 molecules in its portfolio – Roff (rofecoxib, a number two product in its category), Celib (celecoxib) and M-Cam (meloxicam). Several extensions of existing products like Roff injections, Roff plus and Valcox BCD were introduced by Unichem in 2003-04. The company also offers Zulu, another NSAID combination product. It has collaboration with Glenmark Pharmaceuticals.
In Gastro-intestinals area, the company launched Itopride, a GI prokinetic. In Anti-infectives area, the company offers Ampoxin LB, Fixx (cefixime) and Sefdin (cefdinir) in the cephalosporins range of products. In the anti-allergies field, the company offers Le-Zyncet for anti-histamine / antiallergic.
Neu Foreva
Neu Foreva division focuses on psychiatry, neurology, and women’s healthcare areas. In the psychiatry and neurology category, the company offers Serta (sertraline) and Trika SR (alprozolam). The company also offers Escitalopram (CpramS, a variation of Citalopram, an anti-depressant).
The company offers Evacal, which provides calcium supplements to pregnant women, nursing mothers, children and adolescents. The company also launched a microgenised progesterone formulation in the gynaecology range with Uniprogestin M, in addition to other products like Uniprogestin injection, Sulbacin (an antibiotic) and Dubogen (a hormone preparation).
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients (APIs) like anti-amoebics / anti-protozoals, Cox-II inhibitors / NSAIDs, anti-hypertensives / diuretics, anti-depressants, muscle relaxants, anti-asthmatics and decongestants among others, comprise the range manufactured by Unichem. APIs are sold in the domestic and international markets, in addition to being consumed within the company for the manufacture of formulations. DMFs were registered by the company in UK, Norway, France, Germany, Sweden and Italy. The company developed and manufactured Esomeprazole, an antiulcer molecule. In Cardiovascular area, the company develops and manufactures Telmesartan, a cardiovascular molecule.
Market
The company has operations in India, Europe, and the United Kingdom, as well as USA, southeast Asia, Africa and SAARC.
History
Unichem Laboratories Limited was founded by Amrut Mody.
